BERINERT 1500UI powder + solvent for injection medication leaflet

B06AC01 human C1 esterase inhibitor • Blood and blood forming organs | Other hematological agents | Drugs used in hereditary angioedema

Human C1 esterase inhibitor is used for the treatment of hereditary angioedema, a genetic condition characterized by recurrent episodes of severe swelling. It works by regulating the activity of the complement system and preventing its excessive activation.

The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.

Side effects may include headache, nausea, dizziness, or injection site reactions. In rare cases, severe allergic reactions may occur.

This medication is not recommended for patients with hypersensitivity to human plasma proteins or severe IgA deficiency.

General data about BERINERT 1500UI

Substance: human C1 esterase inhibitor

Date of last drug list: 01-07-2015

Commercial code: W61669001

Concentration: 1500UI

Pharmaceutical form: powder + solvent for injection

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: CSL BEHRING GMBH - GERMANIA

Holder: CSL BEHRING GMBH - GERMANIA

Number: 13297/2020/01

Shelf life: 36 months

Pharmaceutical forms available for human C1 esterase inhibitor

Concentrations available for human C1 esterase inhibitor

1500UI, 2000UI, 3000UI, 500 U, 500UI

Other substances similar to human C1 esterase inhibitor